Cipla Ltd gets 6 observations from USFDA for Goa facility

USFDA has conducted an inspection at the Cipla Ltd's manufacturing facility in Goa, India from 10th - 21st June 2024.

On conclusion of the inspection, the Company received 6 (six) inspectional observations in Form 483. The Company will work closely with the USFDA and is committed to address these comprehensively within stipulated time.

Shares of Cipla Limited was last trading in BSE at Rs. 1540.95 as compared to the previous close of Rs. 1544.45. The total number of shares traded during the day was 22260 in over 2856 trades.

The stock hit an intraday high of Rs. 1562.90 and intraday low of 1534.00. The net turnover during the day was Rs. 34457974.00.

Source : Equity Bulls

Keywords

Cipla INE059A01026 GoaFacility USFDA Inspection Form483 6Observations